Table 1 Number of patients with B-level disease activity at study entry in each BILAG body system
Body system | Number of patients | Contributing signs/symptoms* (number of patients) |
|---|---|---|
I. General/constitutional | 3 | Fatigue/malaise/lethargy (3) |
| Â | Â | Anorexia/nausea/vomiting (2) |
| Â | Â | Unintentional weight loss > 5% (1) |
II. Mucocutaneous | 13 | Malar erythema (11) |
| Â | Â | Active localized discoid lesions (2) |
| Â | Â | Mild maculopapular eruption (1) |
III. Neurological | 0 | Â |
IV. Musculoskeletal | 2 | Arthritis (2) |
V. CV/Respiratory | 2 | Dyspnea (2) |
| Â | Â | Pleuropericardial pain (2) |
VI. Vasculitis | 5 | Minor cutaneous vasculitis (nailfold/digital vasculitis, purpura, urticaria) (5) |
VII. Renal | 0 | Â |
VIII. Hematology | 1 | Anemia (hemoglobin < 11 g/dL) (1) |